TABLE 8.
Co-occurrence map of asthma drug-related studies co-cited reference cluster analysis.
| Cluster ID | Silhouette | Mean (year) | Label (LLR) |
|---|---|---|---|
| 0 | 0.865 | 2015 | Severe asthma |
| 1 | 0.918 | 2009 | Bronchial thermoplasty |
| 2 | 0.814 | 1989 | Steroid-dependent asthma |
| 3 | 0.877 | 2002 | Fluticasone |
| 4 | 0.919 | 1998 | Budesonide |
| 5 | 0.938 | 1992 | Phosphodiesterase |
| 6 | 0.903 | 2006 | Long-acting beta-agonists |
| 7 | 0.943 | 1996 | Bronchial hyperreactivity |
| 8 | 0.964 | 2018 | Ovalbumin |
| 9 | 0.993 | 1984 | Animal models |
| 11 | 0.978 | 2009 | Antibiotics |
| 12 | 0.966 | 2012 | Formoterol fumarate |
| 14 | 0.967 | 2003 | Asthma genetics |
| 15 | 0.991 | 1988 | Airway mucosa |
| 18 | 0.999 | 1992 | Metered-dose inhalers |
| 21 | 0.997 | 1991 | Provocation |
| 22 | 0.996 | 2006 | Rhinitis |
| 23 | 0.994 | 2016 | Australia/epidemiology |
| 27 | 0.991 | 2005 | Adenosine |
| 28 | 0.997 | 2003 | Ciclesonide |
| 35 | 0.996 | 2008 | Traditional Chinese medicine |
| 36 | 0.996 | 2002 | Medicaid database |